The lack of a control group is frustrating, but the comparison to outcomes in untreated groups documented in China still makes me feel this treatment holds prom

The lack of a control group is frustrating, but the comparison to outcomes in untreated groups documented in China still makes me feel this treatment holds promise: "For all other patients in this cohort of 80 people, the combination of hydroxychloroquine and azithromycin resulted in a clinical improvement that appeared significant when compared to the natural evolution in patients with a definite outcome, as described in the literature. In a cohort of 191 Chinese inpatients, of whom 95% received antibiotics and 21% received an association of lopinavir and ritonavir, the median duration of fever was 12 days and that of cough 19 days in survivors, with a 28% case-fatality rate (18). The favourable evolution of our patients under hydroxychloroquine and azithromycin was associated with a relatively rapid decrease in viral RNA load as assessed by PCR, which was even more rapid when assessed by culture."